Gene · 4082
Papers2,556
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 2,556
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Peptide Inhibitors of MARCKS Suppress Endotoxin Induced Uveitis in Rats. | J Ocul Pharmacol Ther | 2022 | 35385320 | PubTator, text mining | PubMed |
| Physical and functional interactome atlas of human receptor tyrosine kinases. | EMBO Rep | 2022 | 35384245 | PubTator, text mining | PubMed |
| A kinetic model of phospholipase C-γ1 linking structure-based insights to dynamics of enzyme autoinhibition and activation. | J Biol Chem | 2022 | 35367415 | PubTator, text mining | PubMed |
| ROR2 Downregulation Activates the MSX2/NSUN2/p21 Regulatory Axis and Promotes Dental Pulp Stem Cell Senescence. | Stem Cells | 2022 | 35356984 | PubTator, text mining | PubMed |
| Control of Dendritic Cell Function Within the Tumour Microenvironment. | Front Immunol | 2022 | 35355992 | PubTator, text mining | PubMed |
| Protein kinase inhibitor responses in uveal melanoma reflects a diminished dependency on PKC-MAPK signaling. | Cancer Gene Ther | 2022 | 35352024 | PubTator, text mining | PubMed |
| The role of microRNA in the pathogenesis of glial brain tumors. | Noncoding RNA Res | 2022 | 35330864 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles: Pleiotropic Impacts on Breast Cancer Occurrence, Development, and Therapy. | Int J Mol Sci | 2022 | 35328347 | PubTator, text mining | PubMed |
| Association of children wheezing diseases with meteorological and environmental factors in Suzhou, China. | Sci Rep | 2022 | 35322129 | PubTator, text mining | PubMed |
| The use of serotonin reuptake inhibitors increases the risk of bleeding in patients with assist devices. | BMC Cardiovasc Disord | 2022 | 35317724 | PubTator, text mining | PubMed |
| Fertilization, Oocyte Activation, Calcium Release and Epigenetic Remodelling: Lessons From Cancer Models. | Front Cell Dev Biol | 2022 | 35309905 | PubTator, text mining | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Multivariate genome-wide association study models to improve prediction of Crohn's disease risk and identification of potential novel variants. | Comput Biol Med | 2022 | 35306380 | PubTator, text mining | PubMed |
Protein kinase C targeting of luminal (T-47D), luminal/HER2-positive (BT474), and triple negative (HCC1806) breast cancer cells in-vitro with AEB071 (Sotrastaurin) is efficient but mediated by subtype specific molecular effects. | Arch Gynecol Obstet | 2022 | 35298675 | PubTator, text mining | PubMed |
| T cell receptor engineering of primary NK cells to therapeutically target tumors and tumor immune evasion. | J Immunother Cancer | 2022 | 35288464 | PubTator, text mining | PubMed |
| Regulation of Cell Delamination During Cortical Neurodevelopment and Implication for Brain Disorders. | Front Neurosci | 2022 | 35281509 | PubTator, text mining | PubMed |
| Advances in Multi-Omics Study of Prognostic Biomarkers of Diffuse Large B-Cell Lymphoma. | Int J Biol Sci | 2022 | 35280688 | PubTator, text mining | PubMed |
| Altered Expression of Specific MicroRNAs in Plasma of Aneurysmal Subarachnoid Hemorrhage Patients. | Front Neurol | 2022 | 35242102 | PubTator, text mining | PubMed |
| A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases. | J Transl Autoimmun | 2022 | 35237749 | PubTator, text mining | PubMed |
| Ultra-high sensitivity mass spectrometry quantifies single-cell proteome changes upon perturbation. | Mol Syst Biol | 2022 | 35226415 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4082/papers?page=23